Cerenome, Inc.: updates investor presentation

What happened On Sep 30, 2026, Cerenome, Inc. updated its corporate presentation for use in meetings with investors, analysts and others. A copy of certain updated slides was filed as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference. The report was signed on Oct 2, 2026 by Marc H. Hedrick, M.D., President and Chief Executive Officer.

Key details

• Item 8.01 reported: other events — updated corporate presentation on Sep 30, 2026.
• Exhibit 99.1 filed: Investor presentation as of Sep 30, 2026.
• Item 9.01 reported: financial statements and exhibits, including Exhibit 99.1 and Cover Page Interactive Data File (104).
• Report signed on Oct 2, 2026 by Marc H. Hedrick, M.D., President and Chief Executive Officer.

Why it may matter Item 8.01 covers other events and in this filing relates to the updated corporate presentation. Item 9.01 covers the filing of exhibits, including the investor presentation filed as Exhibit 99.1. This filing does not show why the insider traded or why the company acted.